Her research focuses on deciphering disease mechanisms and developing RNA-targeting therapeutic strategies for neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD).Dr. Sun received her PhD training on the basic mechanisms of RNA processing, especially the regulation of alternative splicing. She then expanded her research repertoire to disease mechanism, therapy development, and mouse genetics during the postdoctoral training. Dr. Sun’s lab is interested in applying RNA Biology knowledge and technologies to decipher molecular mechanism of pathogenesis, identify novel biomarkers and promising drug targets for therapy development by combining innovative techniques and interdisciplinary approaches.